ArticleFrontiers in immunology2023

Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA COVID-19 vaccines in immunocompromised patients.

Chang Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.